# Inside the FIRST Controlled Cannabis Airflow Trial with Dr. Allison Justice > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/controlled-cannabis-airflow-trial-inhalation-dosing/ > **Published:** 2026-03-25T01:05:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:46-04:00 > **Clinical Summary:** Explore the controlled cannabis airflow trial advancing inhalation dosing precision and pharmacokinetics in clinical cannabis research. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic InhalationDosingPharmacokinetics[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)Drug Delivery Why This Matters Controlled airflow studies represent a critical step toward standardizing cannabis inhalation dosing, which remains one of the most challenging aspects of [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) practice. Precise airflow control could enable more predictable pharmacokinetics and reduce the wide inter-patient variability we see with conventional [inhalation methods](https://cedclinic.com/respiratory-effects-inhalational-marijuana/). Clinical Summary This appears to be the first controlled trial examining standardized airflow parameters for cannabis inhalation, though specific methodology and outcomes are not detailed in the available summary. Inhalation remains the most rapidly acting delivery method for cannabis, but dosing precision has been limited by variables including draw technique, lung capacity, and device characteristics. Controlled airflow studies could potentially establish more consistent delivery parameters for clinical applications. Dr. Caplan’s Take “We desperately need this kind of systematic approach to inhalation dosing — it’s been the wild west for too long. If we can control airflow variables, we might finally get closer to the dosing precision that oral formulations provide, but with the rapid onset patients often need.” Clinical Perspective 🧠 Clinicians should monitor developments in controlled inhalation research as it may inform future dosing protocols and device recommendations. Until standardized parameters are established, continue emphasizing start-low, go-slow principles with inhaled cannabis and document patient-specific techniques that produce consistent effects. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Inside%20the%20FIRST%20Controlled%20Cannabis%20Airflow%20Trial%20with%20Dr.%20Allison%20Justice%20-%20Yo...%20%40drcaplan&url=https%3A//www.youtube.com/shorts/tTACNnjmCk0)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.youtube.com/shorts/tTACNnjmCk0)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Inside%20the%20FIRST%20Controlled%20Cannabis%20Airflow%20Trial%20with%20Dr.%20Allison%20Justice%20-%20Yo...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.youtube.com/shorts/tTACNnjmCk0)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.youtube.com/shorts/tTACNnjmCk0](https://www.youtube.com/shorts/tTACNnjmCk0) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What administration method does this research focus on?](#What_administration_method_does_this_research_focus_on) - [What aspects of cannabis pharmacology does this study examine?](#What_aspects_of_cannabis_pharmacology_does_this_study_examine) - [Is this research clinically oriented?](#Is_this_research_clinically_oriented) - [Why is dosing important for inhaled cannabis?](#Why_is_dosing_important_for_inhaled_cannabis) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This study has been assigned a “High Clinical Relevance” rating (#80) by CED. This indicates strong evidence or policy relevance with direct clinical implications for healthcare practice. #### What administration method does this research focus on? The research focuses on cannabis inhalation as the primary method of administration. This delivery method is commonly used in both medical and recreational cannabis consumption. #### What aspects of cannabis pharmacology does this study examine? The study examines pharmacokinetics, which involves how [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) are absorbed, distributed, metabolized, and eliminated by the body. This research also addresses dosing considerations for inhaled cannabis. #### Is this research clinically oriented? Yes, this is [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) that has direct applications for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) practice. The high clinical relevance rating suggests the findings can be immediately applied in healthcare settings. #### Why is dosing important for inhaled cannabis? Proper dosing is crucial for inhaled cannabis because this delivery method has rapid onset and variable bioavailability. Understanding pharmacokinetics helps clinicians and patients achieve therapeutic effects while minimizing adverse reactions. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Inside the FIRST Controlled Cannabis Airflow Trial with Dr. Allison Justice – YouTube”, “url”: “https://www.youtube.com/shorts/tTACNnjmCk0”, “datePublished”: “2026-03-24T20:20:54Z”, “about”: “inside first controlled cannabis airflow trial”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [The study that revealed what a single inhalation of cannabis does to the lungs](https://cedclinic.com/acute-pulmonary-effects-cannabis-inhalation-study/) Discover key findings on the effects of a single cannabis inhalation on lung health and function. [Read the study](https://cedclinic.com/acute-pulmonary-effects-cannabis-inhalation-study/) [Rescheduling marijuana would open the doors for researchers to study THC and CBD.](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) Learn how marijuana rescheduling could enhance research opportunities for THC and CBD clinical studies. [Explore research impact](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) [Marijuana leaf, vapes available to medical cannabis patients under new bill – Yahoo](https://cedclinic.com/vapes-available-medical-cannabis-patients-new-bill/) Updates on new legislation allowing marijuana leaf and vape products for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients. [See legislative updates](https://cedclinic.com/vapes-available-medical-cannabis-patients-new-bill/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).